Ophthalmology. Retina最新文献

{"title":"Papillo-Foveal Bundle Defect: A Course Timeline in Optic Neuritis","authors":"Amber Amar Bhayana MD, Kriti Nausaran MS, Paromita Dutta MD","doi":"10.1016/j.oret.2024.06.002","DOIUrl":"10.1016/j.oret.2024.06.002","url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Page e5"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Validation of the “TWO-ROP” Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center","authors":"Nimesh A. Patel MD ,&nbsp;Francisco Altamirano MD ,&nbsp;Sandra Hoyek MD ,&nbsp;Hanna De Bruyn BS ,&nbsp;Anne Fulton MD ,&nbsp;Ryan Gise MD ,&nbsp;Iason S. Mantagos MD, PhD ,&nbsp;Carolyn Wu MD ,&nbsp;Efren Gonzalez MD ,&nbsp;Deborah K. VanderVeen MD","doi":"10.1016/j.oret.2024.07.010","DOIUrl":"10.1016/j.oret.2024.07.010","url":null,"abstract":"<div><h3>Purpose</h3><div>We aim to validate the previously published TWO-ROP algorithm on an external data set.</div></div><div><h3>Design</h3><div>Retrospective consecutive study.</div></div><div><h3>Subjects</h3><div>Infants screened for retinopathy of prematurity (ROP) between January 2013 and August 2023 at a tertiary referral multi-site.</div></div><div><h3>Methods</h3><div>Infants with higher birth weight (BW) and greater gestational age (GA) were included and stratified into 3 groups as follows: group 1 (BW &lt;1500 g, GA ≥30 weeks), group 2 (BW ≥1500 g, GA &lt;30 weeks), and group 3 (BW ≥1500 g, GA ≥30 weeks).</div></div><div><h3>Main Outcome Measures</h3><div>The rate of ROP, treatment-warranted ROP (TW-ROP), and number of inpatient examinations were evaluated in the 3 groups.</div></div><div><h3>Results</h3><div>In total, 1095 (33.8%) patients met the inclusion criteria. The number of patients in groups 1, 2, and 3 was 837 (76.4%), 72 (6.6%), and 186 (17.0%), respectively. Retinopathy of prematurity was detected in 120 (11.0%) patients; the rate was 9.8% in group 1, 20.8% in group 2, and 12.4% in group 3 (<em>P</em> = 0.013). The overall mean number of inpatient examinations for patients undergoing traditional, TWO-ROP 36-week, and TWO-ROP 40-week screening systems was 1.95, 1.43, and 0.99, respectively (<em>P</em> &lt; 0.001). Stage 3 was found in 9 eyes of 5 patients (0.5%, all zone II). Three eyes of 2 patients (0.2%) had plus disease. Two patients had bilateral laser treatment at 44 and 39.4 weeks postconceptional age (PCA); 3 out of 4 of these eyes met type 1 treatment criteria. Overall, the ROP screening burden saved was 9.0% and 16.7% for the TWO-ROP 36-week and 40-week systems, respectively. The sensitivity for TW-ROP was 100% for TWO-ROP 36-week system and 99.4% for TWO-ROP 40-week system.</div></div><div><h3>Conclusion</h3><div>The TWO-ROP algorithm can reduce the number of inpatient examinations while maintaining safety. To ensure timely management, we recommend that the single first ROP examination occur at 38 to 39 weeks PCA.</div></div><div><h3>Financial Disclosure(s)</h3><div>Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</div></div>","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Pages 63-68"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of Postcataract Surgery Endophthalmitis Managed Without Microbial Cultures","authors":"Annika G. Samuelson MD ,&nbsp;Samir N. Patel MD ,&nbsp;Kapila Kommareddy MD ,&nbsp;Bita Momenaei MD ,&nbsp;Eugene Yu-Chuan Kang MD ,&nbsp;Varun Chaudhary MD ,&nbsp;Jason Hsu MD ,&nbsp;James P. Dunn MD ,&nbsp;James F. Vander MD ,&nbsp;Sunir J. Garg MD","doi":"10.1016/j.oret.2024.07.015","DOIUrl":"10.1016/j.oret.2024.07.015","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate outcomes of eyes with postcataract surgery endophthalmitis that were managed without microbial cultures.</div></div><div><h3>Design</h3><div>This retrospective, single-center comparative cohort study identified all cases of endophthalmitis after cataract surgery presenting between February 1, 2014, and November 1, 2022.</div></div><div><h3>Subjects</h3><div>All eyes presenting with presumed endophthalmitis requiring in-office treatment with intravitreal antibiotics and either a vitreous or aqueous tap were included.</div></div><div><h3>Methods</h3><div>Endophthalmitis cases were divided into the “culture group,” if the vitreous or aqueous specimens were sent for microbiologic sampling, or into the “no culture group” if an aqueous or vitreous tap was performed but not sent for microbiologic sampling.</div></div><div><h3>Main Outcome Measures</h3><div>Best-corrected visual acuity (VA) 12 months after endophthalmitis presentation, incidence of retinal detachment, and need for subsequent procedures.</div></div><div><h3>Results</h3><div>Of the 232 endophthalmitis cases identified, 196 (85%) were in the “culture group” and 36 (15%) were in the “no culture group.” At endophthalmitis presentation, eyes in the “culture group” had a mean (standard deviation [SD]) logarithm of the minimum angle of resolution (logMAR) VA (Snellen equivalent) of 2.14 (0.8) (20/2760) and mean (SD) logMAR VA in the “no culture group” was 1.93 (0.8) (20/1702) (<em>P</em> = 0.185). At 12-month follow-up, mean (SD) logMAR VA for the “culture group” was 0.80 (1.0) (20/126) and 0.41 (0.5) (20/50) in the “no culture group” (adjusted difference = 0.41, 95% confidence interval = −0.043 to 0.857, <em>P</em> = 0.076). Twenty of 196 (10%) eyes in the “culture group” developed secondary retinal detachments within 12 months of presentation compared with 0 in the “no culture group” (<em>P</em> = 0.045).</div></div><div><h3>Conclusions</h3><div>Eyes with endophthalmitis after cataract surgery managed without microbiologic cultures have similar visual outcomes to eyes managed with microbiologic cultures and may be less likely to develop secondary retinal detachments. This may be an acceptable strategy to manage endophthalmitis after cataract surgery when prompt access to a microbiologic facility is unavailable.</div></div><div><h3>Financial Disclosure(s)</h3><div>Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</div></div>","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Pages 40-45"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intravitreal Silicone Oil with a Silicone-free versus a Siliconized Syringe","authors":"Mateus Lins dos Santos MD, MScs ,&nbsp;Lydianne Lumack Monte Agra MD, PhD ,&nbsp;Viviane Santos Cardoso MD, MSc ,&nbsp;Edgar Menezes Neto MD ,&nbsp;Stephanie Marques Araújo MD ,&nbsp;Fernanda Mota Magalhães MD ,&nbsp;Jorge Artur Peçanha de Miranda Coelho PhD ,&nbsp;Gustavo Barreto Melo MD, PhD","doi":"10.1016/j.oret.2024.09.008","DOIUrl":"10.1016/j.oret.2024.09.008","url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Pages 89-91"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical, Genetic, and Histopathological Characteristics of CRX-associated Retinal Dystrophies","authors":"Leo C. Hahn MD ,&nbsp;Isa van der Veen MSc ,&nbsp;Michalis Georgiou MD, PhD ,&nbsp;Mary J. van Schooneveld MD, PhD ,&nbsp;Jacoline B. ten Brink BAS ,&nbsp;Ralph J. Florijn PhD ,&nbsp;Omar A. Mahroo PhD, FRCOphth ,&nbsp;Emanuel R. de Carvalho MD, PhD ,&nbsp;Andrew R. Webster MD, FRCOphth ,&nbsp;Arthur A. Bergen PhD ,&nbsp;Michel Michaelides MD, FRCOphth ,&nbsp;Camiel J.F. Boon MD, PhD","doi":"10.1016/j.oret.2024.08.003","DOIUrl":"10.1016/j.oret.2024.08.003","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;To describe phenotypic, genotypic, and histopathological features of inherited retinal dystrophies associated with the &lt;em&gt;CRX&lt;/em&gt; gene (&lt;em&gt;CRX&lt;/em&gt;-RDs).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;div&gt;Retrospective multicenter cohort study including histopathology.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Subjects&lt;/h3&gt;&lt;div&gt;Thirty-nine patients from 31 families with pathogenic variants in the &lt;em&gt;CRX&lt;/em&gt; gene.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Clinical data of 152 visits were collected from medical records. The median follow-up time was 9.1 years (interquartile range (IQR), 3.3–15.3 years; range, 0.0–48.8 years). Histopathologic examination of the eye of a 17-year-old patient with advanced early-onset &lt;em&gt;CRX&lt;/em&gt;-RD was performed.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Main Outcome Measures&lt;/h3&gt;&lt;div&gt;Visual acuity, retinal imaging, electroretinography, genotype–phenotype correlation, and histopathological examination were evaluated.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The age at onset ranged from birth to the eighth decade of life. Median visual acuity was 1.00 logarithm of the minimum angle of resolution (logMAR) (IQR, 0.69–1.48 logMAR; range, 0.06–3.00 logMAR) at a mean age of 52.0 ± 19.9 years (range, 4.6–81.9 years). Sufficient imaging was available for 36 out of 39 patients (92.3%), and all showed degeneration of at least the macula. Of these 36 patients, 22 (61.1%) had only macular dystrophy. Another 10 patients (27.8%) had additional degeneration beyond the vascular arcades, and 4 patients (11.1%) panretinal degeneration. Two patients (5.1%) had Leber congenital amaurosis. In total, 21 different disease-associated heterozygous &lt;em&gt;CRX&lt;/em&gt; variants were identified (10 frameshift, 7 missense, 2 deletion, 1 nonsense, 1 deletion-insertion variants). Missense variants in the &lt;em&gt;CRX&lt;/em&gt; homeodomain and 2 variants deleting all functional domains, thus causing haploinsufficiency, generally tended to cause milder late-onset phenotypes.&lt;/div&gt;&lt;div&gt;Histopathologic examination of the eye of a 17-year-old patient with advanced early-onset retinal dystrophy due to a heterozygous deletion of exons 3 and 4 of the &lt;em&gt;CRX&lt;/em&gt; gene revealed loss of laminar integrity and widespread photoreceptor degeneration especially in the central retina, with extensive loss of photoreceptor nuclei and outer segments.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;This study illustrates the large clinical and genetic heterogenic spectrum of &lt;em&gt;CRX&lt;/em&gt;-RDs, ranging from Leber congenital amaurosis to mild late-onset maculopathy resembling occult macular dystrophy. Haploinsufficiency and missense variants tended to be associated with milder phenotypes. Patients showed degeneration predominantly affecting the central retina on imaging. The histopathological findings also mirror these clinical findings and features similar to previously reported animal models of &lt;em&gt;CRX&lt;/em&gt;-RDs.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Financial Disclosure(s)&lt;/h3&gt;&lt;div&gt;Proprietary or commercial disclosure may be found in the Footnot","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Pages 78-88"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of Large Submacular Hemorrhage Secondary to Neovascular Age-Related Macular Degeneration","authors":"Sunir J. Garg MD,&nbsp;Carl D. Regillo MD","doi":"10.1016/j.oret.2024.09.006","DOIUrl":"10.1016/j.oret.2024.09.006","url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Pages 1-3"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142927665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"West Nile Retinopathy","authors":"Neil Sheth MD, MBA,&nbsp;Pooja Bhat MD,&nbsp;Michael J. Heiferman MD","doi":"10.1016/j.oret.2024.06.001","DOIUrl":"10.1016/j.oret.2024.06.001","url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Page e4"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Schlaegel Lines 360 Degrees in Punctate Inner Choroidopathy","authors":"Alessandro Feo MD ,&nbsp;David Sarraf MD","doi":"10.1016/j.oret.2024.05.015","DOIUrl":"10.1016/j.oret.2024.05.015","url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Page e2"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fluorescein Angiography of Dark without Pressure","authors":"Michael D. Yu MD,&nbsp;Jose S. Pulido MD, MS,&nbsp;Yoshihiro Yonekawa MD","doi":"10.1016/j.oret.2024.05.013","DOIUrl":"10.1016/j.oret.2024.05.013","url":null,"abstract":"","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Page e1"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retrospective Cohort Study of Sickle Cell Disease and Large Vessel Retinal Vascular Occlusion Risk in a National United States Database","authors":"Gabriel T. Kaufmann MD ,&nbsp;Matthew Russell MD ,&nbsp;Priya Shukla BS ,&nbsp;Rishi P. Singh MD ,&nbsp;Katherine E. Talcott MD","doi":"10.1016/j.oret.2024.07.013","DOIUrl":"10.1016/j.oret.2024.07.013","url":null,"abstract":"<div><h3>Objective</h3><div>To determine if differences exist in the risk of developing large vessel retinal vascular occlusions in patients with sickle cell states.</div></div><div><h3>Design</h3><div>Retrospective cohort study.</div></div><div><h3>Participants</h3><div>Patients with sickle cell disease (SCD) or trait evaluated by an ophthalmologist were compared with matched controls without SCD or sickle cell trait (SCT) also evaluated by an ophthalmologist.</div></div><div><h3>Methods</h3><div>This study used deidentified data from a national database (2006–2024), using International Classification of Diseases 10 codes to select for retinal vascular occlusions. Propensity score matching was performed with respect to age, sex, race, ethnicity, smoking, hypertension, diabetes, dyslipidemias, and obesity, resulting in hemoglobin SS (HbSS), hemoglobin SC (HbSC), and SCT cohorts and matched control cohorts.</div></div><div><h3>Main Outcome Measures</h3><div>Risk ratios (RRs) and 95% confidence intervals (CIs) of retinal vascular occlusion diagnosis, including central retinal artery occlusion (CRAO), branch retinal artery occlusion (BRAO), central retinal vein occlusion, branch retinal vein occlusion, and corneal dystrophy as a negative control, given SCD or SCT.</div></div><div><h3>Results</h3><div>After propensity score matching, HbSS (n = 10 802; mean age ± standard deviation, 38.6 ± 20.6 years), HbSC (n = 4296, 34.3 ± 17.8 years), and SCT (n = 15 249, 39.8 ± 23.7 years) cohorts were compared with control cohorts (n = 10 802, 38.7 ± 20.7 years; n = 4296, 34.6 ± 18.0 years; n = 15 249, 39.9 ± 23.8 years, respectively).</div><div>Patients with SCD (HbSS) had higher risk of developing any retinal vascular occlusion (RR, 2.33; 95% CI, 1.82–3.00), CRAO (RR, 2.71; 95% CI, 1.65–4.47), and BRAO (RR, 4.90; 95% CI, 2.48–9.67) than matched controls. Patients with HbSC disease had higher risk (RR, 3.14; 95% CI, 1.95–5.06) of developing any retinal vascular occlusion than matched controls without SCD. Patients with SCT did not have higher risk of developing retinal vascular occlusions (RR, 1.01; 95% CI, 0.81–1.26) than matched controls.</div></div><div><h3>Conclusions</h3><div>In a retrospective cohort study, patients with HbSS SCD have an increased risk of developing retinal vascular occlusions, and more specifically CRAO and BRAO, compared with patients without SCD.</div></div><div><h3>Financial Disclosure(s)</h3><div>Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.</div></div>","PeriodicalId":19501,"journal":{"name":"Ophthalmology. Retina","volume":"9 1","pages":"Pages 46-51"},"PeriodicalIF":4.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}